Related Experiment Video
Updated: Jul 2, 2025

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
The association of plasma connective tissue growth factor levels with left ventricular diastolic dysfunction in
Huan Li1,2, Yahui Ren3, Linfang Wang4
1Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
Elevated connective tissue growth factor (CTGF) levels are linked to left ventricular (LV) diastolic dysfunction in hyperthyroid patients. Plasma CTGF may serve as an auxiliary biomarker for diagnosing this condition.
Area of Science:
- Cardiology
- Biomarkers
- Thyroidology
Background:
- Left ventricular (LV) diastolic dysfunction predicts cardiovascular events.
- Early detection and management are crucial for improving outcomes.
- Current biomarkers for assessing LV diastolic dysfunction risk are limited.
Purpose of the Study:
- Investigate the association between plasma connective tissue growth factor (CTGF) levels and the risk of LV diastolic dysfunction.
- Evaluate the effectiveness of plasma CTGF as a diagnostic marker for LV diastolic dysfunction.
Main Methods:
- Included 169 patients with overt hyperthyroidism.
- Assessed LV diastolic function and categorized patients into normal and dysfunction groups.
- Analyzed clinical, biochemical, thyroid, and echocardiographic parameters, including plasma CTGF levels.
Main Results:
- Patients with LV diastolic dysfunction exhibited higher age, BMI, and incidences of hypertension, along with lower heart rate, serum albumin, and eGFR.
- Plasma CTGF levels were significantly higher in the LV diastolic dysfunction group (8.290 ng/ml vs. 7.026 ng/ml).
- Higher CTGF quartiles correlated with increased odds of LV diastolic dysfunction, with an AUC of 0.659 for plasma CTGF.
Conclusions:
- Circulating plasma CTGF levels are significantly elevated in patients with LV diastolic dysfunction.
- Plasma CTGF is identified as an independent risk factor for LV diastolic dysfunction.
- Plasma CTGF may offer auxiliary diagnostic value for LV diastolic dysfunction in hyperthyroid patients, potentially outperforming serum BNP.
Background:
Left ventricular (LV) diastolic dysfunction is an independent predictor of future cardiovascular events. Early detection of patients with LV diastolic dysfunction can improve clinical outcomes through active management. However, the assessment of diastolic function is very complicated, and there are currently lack of effective biomarkers to assess the risk of LV diastolic dysfunction. Connective tissue growth factor (CTGF) plays a significant role in cardiac remodeling and dysfunction. We aimed to investigate the associations between plasma CTGF level and the risk of LV diastolic dysfunction in this study and judge its effectiveness in diagnosing LV diastolic dysfunction.
Methods:
A total of 169 patients with overt hyperthyroidism were included. LV diastolic function was evaluated and the subjects were divided into normal LV diastolic function group and LV diastolic dysfunction group. Routine clinical medical data, biochemical data, thyroid related parameters and echocardiographic parameters were recorded for analysis.
Results:
Compared with normal LV diastolic function group, the LV diastolic dysfunction group had higher age and BMI, as well as lower heart rate, lower serum albumin, lower eGFR, higher serum TgAb and BNP level, and the incidences of hypertension were also higher (all P <0.05). Circulating plasma CTGF levels in the LV diastolic dysfunction group were significantly higher (normal LV diastolic function group: 7.026 [5.567-8.895], LV diastolic dysfunction group: 8.290 [7.054-9.225] ng/ml, median [(Interquartile range)], P = 0.004); Compared with the lowest quartile group, the crude odds ratios (OR) of LV diastolic dysfunction in the second, third, and fourth quartile group were 3.207, 5.032 and 4.554, respectively (all P<0.05). After adjustment for the potentially confounding variables, the adjusted OR values of the third and fourth quartile group had no obvious change. The results of ROC showed that the plasma CTGF had the largest area under the ROC curve, and the value was 0.659 (P = 0.005).
Conclusion:
The level of circulating plasma CTGF in the LV diastolic dysfunction group was significantly increased. Plasma CTGF level is an independent risk factor for LV diastolic dysfunction. Compared with serum BNP level, the plasma CTGF level may have auxiliary diagnostic value for LV diastolic dysfunction in hyperthyroid patients.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...